Skip to main content
Immunsystem
Helmholtz Munich | Stefanie Winkler

Protzer Lab

Our scientific interest is to better understand the interaction of hepatitis B (HBV) and C (HCV) virus with their host and to develop new therapeutic strategies to treat chronic viral hepatitis and hepatocellular carcinoma.

Our scientific interest is to better understand the interaction of hepatitis B (HBV) and C (HCV) virus with their host and to develop new therapeutic strategies to treat chronic viral hepatitis and hepatocellular carcinoma.

About our Research

The main focus of our group is to understand in molecular detail the interaction of HBV with its host and its host cell, the hepatocyte. Hereby, we investigate which cellular pathways are involved in the control of HBV replication, which viral proteins may counteract them and how HBV is activated or inactivated by immune mediators and metabolites. In addition, we use the advanced understanding of HBV molecular biology for developing targeted antiviral strategies. Based on thorough analyses of immune responses, we design novel immunotherapies, test them in the preclinical mouse models we have established and promote preclinical development of the most promising ones.

Our Scientists at Protzer Lab

Prof. Dr. Ulrike Protzer

Deputy Head of the Molecular Targets and Therapeutics Center, Director Virology Profil anzeigen

Dr. Marian Wiegand

Project Manager

Dr. Frank Thiele

Postdoc

Dr. Claudia Dembek

Project Manager

Dr. Fuwang Chen

Post Doc

Jinpeng Su

PhD Student

Theresa Asen

Technical Assistant

Susanne Miko

Technical Assistant

Publications

Weiterlesen

Contact

Prof. Dr. Ulrike Protzer

Deputy Head of the Molecular Targets and Therapeutics Center, Director Virology